Clinical Trial for the Evaluation of Efficacy and Safety of Contrast Enhanced Ultrasonography-guided Sentinel Lymph Node Biopsy after Introducing Twirl Breast Marker for Axillary Lymph Node-positive Breast Cancer

Miyake Tomohiro0 个研究点目标入组 20 人开始时间: 2021年6月4日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients with the ability to consent who are 20 years old or older and younger than 90 years old at the time of obtaining informed consent
•(2) Clinically T1-2N1M0 breast cancer patients with 1 to 2 positive axillary lymph nodes of whicn at least one axillary lymph node has been confirmed to harbor metastasis by fine needle aspiration cytology
•(3) Patients whose condition are expected to be stable for longer than 6 months at the time of obtaining the informed consent
•(4) Patients for whom a written consent has been obtained for participation in this study

•(1) Patients with palpable hard nodes
•(2) Patients with radiologically proven matted nodes or gross extranodal disease
•(3) Patients who have been treated with preoperative chemotherapy or hormonal therapy for breast cancer
•(4) Patients who are during or possibilities of pregnancy
•(5) Patients who are allergic to metal or egg
•(6) Patients with coronary artery disease
•(7) Patients who seem not eligible for the present study

发起方

Miyake Tomohiro